Regeneron Pharmaceuticals (REGN) Convertible Debt (2011 - 2015)

Regeneron Pharmaceuticals' Convertible Debt history runs 5 years deep, the most recent figure standing at $30.7 million for Q3 2015.

• In Q3 2015, Convertible Debt fell 89.33% year-over-year to $30.7 million; the TTM figure through Sep 2015 stood at $30.7 million (down 89.33% YoY), while the FY2014 annual figure was $146.8 million, down 54.18% from the prior year.
• Convertible Debt for Q3 2015 stood at $30.7 million, up from $30.4 million in the prior quarter.
• The five-year high for Convertible Debt was $326.7 million in Q1 2014, with the low at $30.4 million in Q2 2015.
• The 5-year median for Convertible Debt is $286.7 million (2012), against an average of $245.1 million.
• The sharpest annual moves came in 2014 and 2015: Convertible Debt rose 8.07% in 2014, then plunged 89.33% in 2015.
• Regeneron Pharmaceuticals' Convertible Debt stood at $275.0 million in 2011, then gained by 7.82% to $296.5 million in 2012, then increased by 8.03% to $320.3 million in 2013, then tumbled by 54.18% to $146.8 million in 2014, then sank by 79.07% to $30.7 million in 2015.
• Business Quant data shows REGN's Convertible Debt at $30.7 million in Q3 2015, $30.4 million in Q2 2015, and $144.1 million in Q1 2015.